Committed to improving women’s health and quality of life
Arkady Rubin, PhD
Founder, Chief Scientific Officer, Acting CEO
Chief Operating Officer
VP, Marketing & Corporate Communications
A 30-year industry veteran (J&J, Pfizer) and a co-inventor of Ortho Tri-Cyclen Lo, the best-selling oral contraceptive in the U.S. Dr. Rubin majorly contributed to the development of top contraceptive brands.
A founder of one of the largest medical association management firms with a COO experience in a women's health company.
An executive who was responsible for marketing and corporate communications in a public women's health pharmaceutical company
Get in Touch
Wendy J. Weiser
Jason Spitz, MBA
Clinical, Commercial and Technical Advisors
120+ years of successfully developing leading women's health brands.
Agis Kydonieus, PhD
Drug Delivery Advisor
Andrea S. Lukes, MD, FACOG
Lead Clinical Advisor
Jeffrey Frick, MBA
Alan N. Walter, JD
Legal Affairs Advisor
Russell Barrans, MBA
Commercial Strategy Advisor
Barbara Levy, MD, FACOG, FACS
Medical Afffairs Advisor
Kate McKinley, MBA
Strategic Leadership Advisor
Consultant for PREMRING. Co-founder of the Controlled Release Society, holder of 55 U.S. patents, the author of 10 books on drug delivery.
Dr. Lukes has conducted >80 clinical trials of women's health products. She has published in OB/GYN journals and served on the FDA advisory committees.
Women's health advocate and executive, an expert in health care access and previous ACOG’s Vice President for health policy.
A former CEO of a successful oncology company and a member of several Boards of Directors. An expert in fundraising, M&A, and alliance management
As a VP of Marketing at Berlex Labs, Mr. Frick contributed to the successful contraceptive launches (Yasmin®, YAZ®, Mirena®) with combined sales of $2B.
An award-winning commercial expert who has helped introduce or reposition widely known contraceptive brands. 30 years of elevating women's healthcare.
Commercial law and business expert with over 25 years of experience with capital raises, M&As, private placements, and equity investments.